Pharmaceutical manufacturer scaling SAP operations across production and supply chain
Aristo Pharmaceuticals operates a 5,000–10,000-person manufacturing business anchored on SAP infrastructure, with active implementation of Production Planning and Quality Management modules underway. The project roadmap reveals a company in the midst of a system-wide integration effort—PP/QM rollout, cross-module connectivity (MM, SD, FI/CO), and post-go-live stabilization dominate current work. Pain points around production support, module integration complexity, and statutory compliance suggest operational strain typical of mid-scale pharma transitioning from legacy systems.
Aristo Pharmaceuticals manufactures pharmaceutical products for mass-market and niche segments, operating primarily in India with headquarters in Mumbai since 1971. The company employs 5,001–10,000 people across manufacturing, supply chain, sales, and corporate functions. Core operations run on SAP with modules covering production planning, quality management, materials management, sales & distribution, and financials. Current hiring remains India-focused and steady, with near-term staffing needs scattered across engineering, operations, manufacturing, and finance—reflecting the demands of the ongoing SAP implementation cycle.
Aristo runs SAP as its primary enterprise platform, with active deployment of Production Planning (PP) and Quality Management (QM) modules, alongside Materials Management (MM), Sales & Distribution (SD), and Financial modules (FI/CO).
Aristo is executing a multi-phase SAP transformation: PP/QM module implementation and customization, master data governance, cross-module integration, post-go-live stabilization, and payroll process standardization and automation.
Other companies in the same industry, closest in size